Skip to main navigation Logo - Color Investor FAQ On which exchange is Verastem Oncology™ listed and what is the ticker symbol and when did it go public? Verastem Oncology is traded on the NASDAQ global market under the symbol VSTM, and its CUSIP number is 92337C 104. Verastem’s initial public offering (IPO) occurred on January 27, 2012 Where is Verastem Oncology incorporated? Verastem Oncology is incorporated in the state of Delaware. Where is Verastem Oncology headquartered? Verastem Oncology is headquartered at 117 Kendrick Street, Suite 500, Needham, MA 02494, U.S. The main phone number is 781-292-4200. Do you pay dividends or is there a reimbursement plan? Verastem Oncology does not currently offer a dividend or stock reimbursement plan Who is Verastem Oncology’s transfer agent? Computershare Trust Company, N.A. P.O. Box 43078 Providence, RI 02940 www.computershare.com 1-800-962-4284 (from the US, Canada, Puerto Rico) 1-781-575-3120 (non-US) If my address changes, whom should I notify? You must send both your old and new address to our transfer agent, Computershare Trust Company, N.A., by U.S. mail. Each stockholder in question must sign the request for an address change. What is Verastem Oncology’s fiscal year-end? December 31. Who are Verastem Oncology’s independent auditors? Ernst & Young LLP 200 Clarendon Street Boston, MA 02116 617-266-2000 Who is Verastem Oncology’s legal counsel? Ropes & Gray Prudential Tower 800 Boylston Street Boston, MA 02199-3600 T +1 617 951 7000 Who should I contact if I have further questions? Verastem Oncology's investor relations department is happy to answer any shareholder questions. You may contact Verastem Oncology's investor relations by phone at 781-292-4200, or by email at info@verastem.com E-mail Alerts You may automatically receive Verastem Oncology financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit. Required fields denoted by an asterisk (). Alert Type Verastem Inc End-of-Day Stock Quote Alert Verastem Inc SEC Alert Verastem Inc Calendar Alert Verastem Inc News Alert Email Investor Contact Ajay Munshi Investor Relations 781.469.1579 info@verastem.com Sherri Spear Argot Partners 617.533.0020 sherri@argotpartners.com Investor Kit Corporate Presentation Corporate Latest 10-K Corporate Proxy Statements Corporate Compliance & Business Practices Terms of Use Copyright Statement Privacy Policy Contact © 2021 Verastem, Inc. All Rights Reserved.